共 178 条
[4]
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
[J].
GYNECOLOGIC ONCOLOGY,
2008, 109 (02)
:174-181
[6]
[Anonymous], J NATL CANC I
[7]
[Anonymous], 2018, Oncotarget, DOI 10.18632/oncotarget.23552
[8]
[Anonymous], 2018, Oncotarget, DOI DOI 10.18632/ONCOTARGET.22840